ScanGrants is a public service listing of grants and other funding types to support health research, programs and scholarship.
21 funding opportunities found in this category. Change the order of results:
Lowest Award to Highest
Highest Award to Lowest
American Epilepsy Society Seed Grant Program
This program is intended to foster collaborative interactions between two or more established investigators* to make future grants related to epilepsy more competitive for larger awards, and to fuel multi-investigator projects. These small awards are designed to enable information exchange/technology transfer, travel of postdoctoral fellows between laboratories, and modest supplies for the project. These awards are designed to provide seed monies to investigators. Funds are total costs. No allowance for indirect costs will be awarded over the $20,000 maximum funding level.
*An established investigator is defined as having at least an Associate Professor or equivalent level appointment, and who has a history of successful NIH/NSF/VA funding. Their work can be focused on basic, translational, or clinical research.
• At least one PI must be an active member of the Society
• Must be a new initiative that will add value to the field or fill a gap in knowledge
• Techniques in a collaborative effort must be complementary
• Must involve two or more established investigators, at least one of which is an epilepsy-focused investigator.
• Although not required, trans-disciplinary projects, projects integrating clinical and basic research, and research directions with translational relevance are encouraged.
• Also encouraged are collaborations between geographically separated laboratories, or between laboratories in highly disparate scientific disciplines (e.g. neuroscience and engineering).
Funding: A maximum of five one-year grants in the amount of $20,000 each will be awarded annually. Grants are non-renewable.
Application should be no more than two pages not counting the face page and include:
a) a face page
b) an overview of the research and technical expertise of the participating laboratories/clinical research sites.
c) the research collaboration that is proposed,
d) how the seed grant mechanism will foster this research and the overall collaboration, and
e) a budget.
Applications should also include an NIH format Biosketch for all principal investigators, including present and past funding. This Biosketch should highlight the 5 most significant publications of each investigator published over the past 10 years,
There are three rounds of consideration each year. Applications will be reviewed by a committee of the Research & Training Council and results will be announced within six weeks of the application deadline.
Submission deadlines (no extensions):
• March 28, 2014
• June 27, 2014
• September 26, 2014
Applications (in PDF format) should be sent to the AES Office by email to firstname.lastname@example.org by close of business on the date of the deadline.
American Nephrology Nurses' Association Evidence–Based Practice Project Grant
First Proposal Submission (Optional) for Review and Research Committee Feedback: August 31, 2014
Final Proposal Submission: November 15, 2014
To fund qualified nephrology nurses’ work to translate research into practice in support of developing evidence-based nephrology nursing practice and demonstrating the value of nephrology nursing in improving patient outcomes.
PROJECT TYPES ELIGIBLE FOR FUNDING*
• Primary Research: funding on a smaller scale as compared to the research grant award. Pilot studies, and partial funding for research projects, thesis, or dissertations.
• Evidence Summary: synthesis of the body of research on a topic of relevance to practice into a single, meaningful statement of the state of the science. Examples include systematic review, meta analysis, review of the literature.
• Research Translation: translation of evidence into practice recommendations. Examples include: clinical practice guidelines that may include clinical pathways, protocols, and algorithms.
• Integration: adoption of a practice change based on evidence. This involves changing both individual and organizational practices through formal and informal channels. Examples include implementation of a clinical pathway based on evidence found in the literature, use of an evidence-based algorithm found in the literature.
• Evaluation: evaluation of an EBP project already implemented in the clinical setting.
• Other projects. Examples include: staff development programs on topics such as evidence based practice, learning to evaluate the research literature, how to effectively conduct a literature search, development of patient teaching materials that are evidence-based, implementation of a journal club to introduce EBP. Consult with the Research Committee to determine appropriateness of other project ideas.
*Project categories are based on the ACE Star Model of Knowledge Transformation. The complete reference appears at the end of the grant application.
SELECTION OF RECIPIENT
1. The Research Committee will review and score the proposals for scientific merit and feasibility based on the criteria stated below.
2. ANNA will award funding based on established research and clinical practice priorities and availability of funds.
Three (3) ANNA grants up to $5,000 per proposal will be awarded each year at the National Symposium by the Research Committee Chair.
1. Candidates must apply for the grants.
2. The principal investigator must be a full member of ANNA for the duration of the evidence-based practice research project. If two (2) or more individuals are applying as co-investigators, all must be members of ANNA for the duration of the research project with at least one (1) of the co-investigators being a full member, and others being either full or associate members.
3. Actively involved in nephrology nursing related health care services.
4. The principal or co-principal investigator(s) who are full members of ANNA must share equal responsibility with all other co-investigators for the conceptualization and implementation of the proposed research project.
5. The principal or co-principal investigator(s) who are full members of ANNA must provide evidence of his/her/their experience and credentials demonstrating the ability to complete the evidence-based practice project and commitment to nephrology nursing.
6. Applicants are encouraged to contact a member of the ANNA Research Committee to discuss ideas and use the assistance of the committee to connect them with appropriate mentors, if the committee member determines this is needed.
7. Eligible projects must be focused on the development of an evidence base for nephrology nursing and relevant to nephrology nursing practice, using the ANNA Nephrology Nursing Scope and Standards of Practice (2011) as a guide.
8. The project may be a new endeavor or one already in progress.
9. Other funding sources must be disclosed.
10. A separate proposal submitted under a different principal investigator or a different project title for the same study will not be eligible to receive a grant through this or any other ANNA sponsored research program.
11. The proposal must demonstrate the following:
a. Problem statement defining the clinical problem and why is this important to nephrology nursing.
b. Evidence that supports use of the intervention that will address the clinical problem.
c. Project description: population, steps that will be taken to complete the project.
d. Evaluation of project outcomes.
e. Relationship to the Nephrology Nursing Scope and Standards of Care
f. Approval by the appropriate institutional review board.
g. Feasibility and likelihood of successful completion.
h. A detailed budget for the proposed project should be outlined including costs that exceed the grant
amount. While indirect costs may be included in the budget, ANNA does not fund indirect costs.
12. The ANNA Board of Directors reserves the right to make the final decision on all grant monies awarded.
Society of Critical Care Medicine Vision Grant
The Society's Vision Grant offers up to $50,000 in funding to members conducting basic, translational or clinical research specifically related to the organization's mission to secure the highest quality care for all critically ill and injured patients.
SCCM seeks to sponsor research efforts that will ultimately improve patient care in the ICU. Investigator-initiated research should help advance and improve our understanding of critical illness and patient care.
Interest is broad. Applications are encouraged that focus on expanding our basic knowledge of critical illness, clinical interventions to improve patient outcomes, technical aspects - such as electronic surveillance systems -- as well as studies exploring cultural and educational factors among ICU staff that either impede or facilitate a climate promoting best practice and error reduction. Priority will be given to projects that have broad relevance. Single-center projects, for example, should specifically address the potential to generalize their findings to other critical care settings.
Submission and Deadline
APPLICATION SUBMISSION DEADLINE: AUGUST 11, 2014.
One electronic copy of the application must be received by August 11, 2014.
Please submit the electronic copy to Vision Grant, utilizing the "Request a delivery receipt" and "Request a read receipt" functions.
All submissions are to be in PDF format and compiled as one document.
The principal investigator must be a current SCCM member and maintain SCCM membership through the life of the grant. Applications are encouraged from junior and established investigators. Applications from junior investigators (defined as no prior independent NIH funding - RO1 or equivalent - and within 10 years of finishing their training) may request independent support or may include a research mentor who is also an SCCM member and can demonstrate strong research credentials in the areas of clinical and outcomes research. Previous recipients of the Vision Grant may not reapply for a period of five years from the date of the previous grant award.
American Society of Hematology Scholar Awards
The ASH Scholar Awards are designed to support hematologists who have chosen a career in research by providing partial salary or other support during that critical period required for completion of training and achievement of status as an independent investigator.
Awards are limited to a maximum of $100,000 for fellow scholars and $150,000 for junior faculty scholars over a two- to three-year period, with an annual maximum of $50,000 for fellows and $75,000 for junior faculty. Up to 15 percent of the award can be (but is not required to be) used for benefits, including medical and dental insurance, life insurance, and retirement benefits.
All awards are activated on July 1 of the following year. The applicant has the option of concluding the award on June 30, two or three years after activation. All award payments are made on a quarterly basis - the amount depends on whether the award is being spread over two or three years. Payments are made to the appropriate financial officer of the institution as indicated on the proposed budget within the full application.
ASH considers basic research to include a broad spectrum of studies on genes, proteins, lipids, carbohydrates, biochemical and signaling pathways, receptors, cells and animals, as well as samples obtained from humans, all of which are designed to further our understanding of the blood, bone marrow, and related organs or the pathogenesis of blood disorders. The emphasis for grants in this category should be on the discovery of new knowledge in a traditional laboratory setting.
ASH defines translational research as using knowledge of human biology to develop and test the feasibility of relevant interventions in humans and/or determine the biological basis for observations made in individuals with hematologic conditions or in populations at risk. Translational research should be founded on and directly connected to some aspect of human biology and may encompass any form of structural, biochemical, genetic, or other appropriate experimental approaches using human materials. The proposal should address clinical applications - not just test development - although the development of novel instrumentation of value to hematology is clearly within the scope of the application. Clinical trial projects with laboratory correlatives are considered clinical.
Clinical Research: ASH considers clinical/translational research to include patient-oriented research and outcomes-based research. ASH emphasizes that clinical research must involve substantial interaction with patients.
For the purposes of the ASH Scholar Awards program, patient-oriented research is defined as research conducted with human subjects and involves an investigator directly interacting with human subjects. Categories of patient-oriented research include: 1) mechanisms of human disease, 2) therapeutic interventions, 3) clinical trials, and 4) development of new technologies.
ASH strongly encourages applications in outcomes-based research. Options for outcomes-based research include: 1) a decision-analysis or cost-effectiveness analysis of a relevant topic within hematology, 2) survey-based research investigating practice patterns, access to care, quality of care, clinical outcomes, or quality of life among patients with hematologic conditions, 3) retrospective analyses of large administrative databases (e.g., CMS, a large insurer, SEER) that may enlighten health care policy decisions related to hematologic disease, and 4) large scale epidemiologic or genetic epidemiologic studies that define the incidence, prevalence, prognosis, and natural history or the effects of therapy of blood disorders.
Applications that fall within any of the categories discussed above are encouraged.
Letter of Intent Due: Wednesday, May 7, 2014
Application Made Available for Those Who Successfully Submit a LOI by the Deadline: Thursday, June 5, 2014
Application Deadline Friday, August 1, 2014
Award Winners Notified: Mid-November, 2014
Activation of Award: Wednesday, July 1, 2015
These eligibility requirements are evaluated as of the date of the LOI submission.
Eligible applicants must be a citizen of the United States or Canada or hold a visa in the United States or Canada.
Eligible applicants must conduct research within the US or Canada
Scholar Award applicants are required to be members of ASH in good standing at the time of the Letter of Intent submission, and for the duration of the Scholar Award Program. If your membership application is pending at the time of the Scholar Award application deadline, you will still be considered for a Scholar Award.
To verify your membership status, please log on to the membership section of the ASH website. If you need assistance with your username and password, please contact an ASH Customer Relations Representative at email@example.com.
Fellow Scholar Awards
PhD or MD/PhD applicants must have fewer than 5 years of research experience after completion of their PhD (including research performed during fellowship, but excluding clinical fellowship time)
MD applicants should have more than 3 but fewer than 5 years of research experience (including research performed during fellowship, but excluding clinical fellowship time)
MD applicants with fewer than 3 years research experience (inclusive of fellowship research time) should consider applying for the Senior RTAF award
Applicants with the title of Assistant Professor or equivalent *must* apply for the Junior Faculty Award, regardless of research experience
Junior Faculty Scholar Awards
MD, PhD or MD/PhD applicants must have more than 5 but fewer than 10 years of research experience after completion of their PhD (including research performed during fellowship, but excluding clinical fellowship time)
Applicants with the title of Assistant Professor or equivalent *must* apply for the Junior Faculty Award, regardless of research experience.
American Society of Hematology Bridge Grant Program
All applicants must submit proposals to conduct research in hematology.
ASH considers basic research to include a broad spectrum of studies on genes, proteins, lipids, carbohydrates, biochemical and signaling pathways, receptors, hematopoietic cells, and samples obtained from human patients or from vertebrate animal models. For the purpose of this grant, hematology-related basic research is designed to further our understanding of the blood, bone marrow, and related organs and/or the pathogenesis of blood disorders. The emphasis for grants in this category should be on the discovery of new knowledge in a traditional laboratory setting.
ASH defines translational research as using knowledge of human biology to develop and test the feasibility of relevant interventions in humans and/or determine the biological basis for observations made in individuals with hematologic conditions or in populations at risk. Translational research should be founded on and directly connected to some aspect of human biology and may encompass any form of structural, biochemical, genetic, or other appropriate experimental approaches using human materials.
Patient-Oriented Clinical Research
Patient-oriented research is defined as research conducted with human subjects and involves an investigator directly interacting with human subjects. Categories of patient-oriented research include: 1) mechanisms of human disease, 2) therapeutic interventions, 3) clinical trials, and 4) development of new technologies.
Options for outcomes-based research include: 1) a decision-analysis or cost-effectiveness analysis of a relevant topic within hematology, 2) survey-based research investigating practice patterns, access to care, quality of care, clinical outcomes, or quality of life among patients with hematologic conditions, 3) retrospective analyses of large administrative databases (e.g., CMS, a large insurer, SEER) that may enlighten health-care policy decisions related to hematologic disease, and 4) large scale epidemiologic or genetic epidemiologic studies that define the incidence, prevalence, prognosis, and natural history or the effects of therapy of blood disorders.
Application deadline: June 1, 2014
Application notification of acceptance: Mid-Late July, 2014
To be eligible for the ASH Bridge Grant Award all applicants must:
Have submitted a hematology-related R01 or equivalent application to NIH in the past 18 months that was scored but not funded.
ASH uses the NIH definition of R01 equivalence: “R01-equivalent awards include R01, R23, R29, and R37 activity codes and, beginning in fiscal year 2008, DP2 awards to first-time NIH investigators. Not all of these activities are in use by NIH every year.”
The 18 month timeline is linked specifically to the date your R01 was reviewed by the NIH study section.
Be an ASH member or have a pending application for membership at the time of application.
If you have a pending application and are awarded a Bridge Grant Award, your award will be conditional based upon membership approval
Hold a faculty position in an academic institution or the equivalent position in a non-profit research organization. Employees of independent research institutions are eligible to apply if they have a faculty type appointment and the institution is allowed to independently apply for and receive NIH funding.
At the time of award activation, the amount of other research funding available to the principal investigator may not exceed $250,000 annually. This amount does not include the applicant’s salary/fringe and funding from within the institution.
Hematologists eligible to apply for the ASH Scholar Award are not eligible to apply for this award.
Individuals cannot hold an ASH Scholar Award and ASH Bridge Grant concurrently. ASH Scholars can apply if their award terminates before the commencement of the bridge grant.
Applicants can apply a maximum of three times over the three-year award program.
Previous Bridge Grant award recipients cannot apply for a second award.
Society of Anesthesia and Sleep Medicine Research Grant
This grant supports further research in areas common to the fields of Anesthesia and Sleep and Pulmonary Medicine. Appropriate proposals will be those requesting funds for pilot data with clear intention for a subsequent grant application to a larger source of federal or non-federal support. Therefore the principal investigator must be eligible to submit such an application.
Funding priority will be given to the projects that illustrate:
Clear plans for extramural submissions.
Direct clinical and translational impact.
Clear ability to complete the research within a one year period.
New investigators, trainees and K awardees
Maximum Grant Award: $20,000 dollars for one-year period
NIH biosketch of the PI. Trainees can apply with a faculty as co-PI.Contact information for the PI and the co-investigators.Applicant should be an active member of the SASM.Active IRB approval letter is mandatory at the time of acceptance of grant. The grant will be awarded at the SASM annual meeting in October 2014.A maximum of 3-page application with full description of background, study hypothesis, objective of study, methods, expected results and feasibility. A minimum margin of 2 cm (3/4 inch) around each page is mandatory. A font size of 12 point, black ink should be used, with 6 lines of text per inch, and no condensed type or spacing.
The PI as well as the co-PI must be members of Society of Anesthesia and Sleep Medicine
The application must include:
a) A short 5–10 sentence summary presenting the essential elements of the proposal.
b) Two to four sentences addressing the translational impact of the project. Specifically, how the results of the research will lead to improvements in human health or disease.
c) Two to four sentences addressing the applicant’s plans for turning the results of a funded proposal into future grant application/ QI project / publication.
A separate one-page detailed budget of services and justification including costs per unit and number of units and hours needed etc. Applications lacking sufficient detail will be returned to the applicant.
Pertinent references and figures to be included in the Appendix section of the application.
Applications will be reviewed by the Research Grant Committee of the Society of Anesthesia and Sleep Medicine.
SASM is neither responsible for, nor will award any indirect costs associated with any research grants/funding awarded on its behalf.
Project Completion Report
At project completion, the PI must submit a brief report summarizing the results of the project and plans for presentation, publication and submission for external grant applications. Failure to provide a project completion report will be viewed negatively when considering future applications from the PI.
Submission Method and Deadlines
Applications should be submitted as a pdf to the SASM office by mail or email by July 1 2014.
SASM (Research Grant)
6737 W Washington St, Ste 1300
Milwaukee, WI 53214
P: (414) 389‑8608
F: (414) 276‑7704
The winning application will be announced at the SASM Annual Meeting on 9–10 October, to be held immediately prior to the American Society of Anesthesiologists ASM in New Orleans.
Contact the SASM office by email at firstname.lastname@example.org or by phone at 414–389-8608.
Call for Applications: American Society of Transplantation Translational Science Faculty Development Grant
Applications must be submitted by Monday, September 15, 2014. The funding of any grant and total number of grants awarded by the AST is dependent on budgetary constraints in a given year.
The AST Translational Science Faculty Development Grants are intended to support projects involving human tissue or other biologic material for in vitro examination to address a clinical issue related to transplantation. In general, these studies should link the in vitro results to other data or outcomes from the same patients to be considered a translational research faculty proposal.
2015 Translational Science Research Priorities
The AST has identified the following translational research priorities for 2015, and encourages investigators working within these areas to apply for funding by the AST:
Studies to identify and validate surrogate markers for long-term outcomes
Studies to determine the effects of cell therapies on protective immunity (e.g. does infusion of Tregs or MSC alter patient defense against microbial pathogens or cancer?)
Studies to define predictors and/or mechanisms of disease after transplant (i.e. cardiovascular disease, recurrent GN, de novo HLA antibodies or chronic rejection)
Identify specific molecules and/or molecular mechanisms that explain the roles of the microbiome in immunity and transplant outcomes (note: purely descriptive profiling of microbiomic changes is not responsive to this area)
The role of epigenetics in determining transplant outcomes
This is a one- or two-year $50,000/year grant for Junior Faculty. The goal of the AST Translational Science Faculty Development Grant is to promote the careers of young independent investigators within the first five years of their first faculty appointment (see eligibility criteria), by providing funds allowing them to expand on preliminary research findings that will become the basis for individual research or career development awards from the NIH, VA, or equivalent agencies.
The AST supports a wide range of basic, clinical and translational research topics. Research topics that involve under-represented areas including minorities, women, and pediatrics are strongly encouraged. The AST also encourages applications from women and minority researchers. Under-represented minority investigators are defined as individuals belonging to a particular ethnic or racial group as determined by the NIH. Established AST members are encouraged to bring this funding opportunity to the attention of new faculty members performing transplantation research at their institutions and to support their applications.
Eligibility Criteria for the AST Translational Science Faculty Development Grant
Please pay particular attention to the eligibility requirements, as requirements vary for different AST Grants.
Academic Appointment and Institutional Resources: The applicant must have an academic appointment at an accredited institution of higher learning and be within five years of his/her initial academic faculty appointment at the time of the grant application. Regardless of academic title (including instructor, research associate, or equivalent), the AST defines initiation of faculty appointment as the date that the applicant obtained an institutional commitment towards an independent career which includes: a) an office distinct from lab space and/or independent lab space; and b) a start-up package or grant funds controlled by the applicant to work on projects that are independent from his/her mentor. For all applicants, a letter from the Department Chair is required that explicitly addresses: a) the date (month/year) of the first faculty appointment; b) that institutional commitment to the faculty member is sufficient to conduct independent research; c) the amount of protected research time (at least 75%) should this grant be awarded; and d) independence.
Failure to adequately document that the applicant is an independent faculty member with less than five years’ experience will disqualify the application without further review. The applicant must state the date (month and year) of their first faculty appointment in the appropriate space on the contact information page of the application. Note that changing institutions once after having already become a faculty member does not restart the five year time period.
The five year time-frame may be extended if there are extenuating circumstances requiring a leave from relevant academic activities (e.g. child-bearing, armed services commitment). These will be considered on a case-by-case basis and must be accompanied by a letter of explanation by the applicant.
An individual may apply for the AST Faculty Grant while still in training, however, he/she must have been offered and accepted a faculty position that will begin on or before initiation of the grant. In this case, the applicant must submit a letter from the Department Chair of his/her future department that confirms the institutional appointment and provides assurance that the candidate will have an office and/or independent lab space. The letter should also confirm that the candidate will have sufficient start up funds to carry out the project that are independently controlled by the candidate to perform his/her work independently from his/her mentor. Additionally, the letter should stipulate the amount of protected research time (at least 75%) should this grant be awarded.
AST Membership: The applicant must be an active member of the AST or have submitted a completed membership application by September 15, 2014 (with expectation that membership will be active before the grant review occurs). Applicant’s membership dues must be paid to date by November 1, 2014, otherwise, the application will not be considered for funding.
The proposed work is to be performed in a North American laboratory.
Education: The applicant must have an MD, DO, PhD, DVM, or equivalent graduate degree, and have completed post-graduate training (residencies, post-doctoral fellowships, etc.) at the time of the application.
Citizenship: The applicant must be either: a) U.S., Canadian, or Mexican citizen; b) a lawfully admitted permanent resident foreign national of the U.S., Canada, or Mexico with a valid visa during the awarded period; or c) a foreign national admitted lawfully for residence in the U.S., Canada, or Mexico during the awarded period. Funding will not be released until visa status is confirmed.
Previous/Additional Funding: An individual cannot apply for an AST Clinical Science Faculty Development Grant if he/she has been awarded any AST Faculty Grant (or joint grant between AST and another society) in the past. A candidate is also ineligible if they are a PI on a previous or current NIH grant to perform independent research (RO1, project on a PO1 grant,R21, VA Merit award or comparable non-mentored award). However, an applicant may have current or previous Career Development Awards or Grants-in-Aid. A concomitant K Award or comparable mentored award is permitted if the applicant is ready to establish independence of previous mentors and has already become or has been offered and accepted an independent faculty position, as defined above. This should be specifically addressed in the letter from the Department Chair.
The AST Translational Science Faculty Development Grant project must be distinct from that of any concurrent award. Moreover, this work should not directly overlap with funded projects of other faculty members within the same Section or Department.
Note: Faculty may only hold ONE new AST Grant per year as a PI of a Faculty Development Grant, or as mentor/sponsor of a Fellowship Grant. If more than one grant from a given faculty member (as PI or mentor) is submitted and deemed competitive for funding, the AST will determine which grant to fund.
Call for Applications: American Society of Transplantation Translational Science Fellowship Grant
The AST Translational Science Fellowship Grants are intended to support work that addresses important translational research questions in transplant candidates, recipients and or donors. The project should provide a strong training vehicle for the applicant, in keeping with the overall mission of the AST Fellowship Grants.
2015 Translational Science Research Priorities
The AST has identified the following research priorities for 2015, and encourages investigators working within these areas to apply for funding by the AST:
This is a one- or two-year $50,000/year grant designed to provide salary support for fellows at an early stage of their research training (see Eligibility Criteria). The goals of the AST Fellowship Grants are:
To foster training of new young investigators who have the potential to contribute to our understanding of transplant science/immunobiology and/or treatment of transplant recipients.
To foster research that is of high merit.
To encourage high quality applicants who want to develop a career in academic transplantation.
Translational research includes projects involving human tissue or other biologic material for in vitro examination to address a clinical issue related to transplantation. In general, these studies should link the in vitro results to other data or outcomes from the same patients to be considered a clinical research faculty proposal.
Eligibility Criteria for the AST Translational Science Fellowship Grant
The applicant must be sponsored by an active member of the AST. If the sponsor is not a member, he/she must submit a completed membership application by September 15, 2014 (with expectation that membership will be active before the grant review occurs). Membership dues must be paid to date by November 1, 2014; otherwise, the application will not be considered for funding.
The work must be performed at a North American site under the direct mentorship of an AST member.
The applicant must have an MD, DO, PhD, DMV or equivalent graduate degree at the time of the application.
AST Fellowship Grants are meant for individuals who have spent two years or less (at the time of the application) performing research in the area of transplantation since obtaining their last post-doctoral degree (MD, PhD, or equivalent degree). Applicants who have worked in other fields or taken leaves of absences are eligible beyond this two-year period, but this must be directly addressed in the sponsor's letter.
The applicant must be either: a) a US, Canadian or Mexican citizen; b) a lawfully admitted permanent resident foreign national of the US, Canada, or Mexico with a valid visa during the training period; or c) a foreign national admitted lawfully for residence in the US, Canada, or Mexico during the training period. Funding will not be released until visa status is confirmed.
Throughout the period of the grant, the applicant must be at a "fellowship training" level, may not hold an independent faculty level position or a salaried senior staff position (or equivalent). The AST defines an independent faculty level position as: a) Assistant Professor or equivalent; or b) Regardless of title, institutional support that includes independent lab space and/or start-up funds to allow independent research. The applicant does not need to have actually started their fellowship at the time of application.
The Fellowship Grant is intended to support or supplement salary during the period of research training.
Residual funds can be used for supplies. Funds cannot be used for indirect costs or institutional overhead.
Fellows who have other individual fellowships or grants awarded in their name that support their salary, are not eligible.
The sponsor must guarantee 75% protected time adequate for project completion.
Americas Hepato-Pancreato-Biliary Association Research Grant
The Americas Hepato-Pancreato-Biliary Association is pleased to sponsor the AHPBA Research Grant. The purpose of this award is to provide the opportunity for a resident or fellow to spend one year of full time research under the mentorship of an AHPBA member. Residents or fellows who have completed at least two years of post-graduate training in a surgical discipline are eligible to apply. The research can be clinical, outcomes, translational, or basic science, but must focus on the liver, pancreas, or biliary tree. The amount of the award is $30,000. Application deadline is January 5, 2015.
Call for Applications: Early Career Investigator Travel Fellowship for Demyelination and Remyelination: From Mechanism to Therapy
Thursday, June 26, 2014 7:45 AM - 5:45 PM The New York Academy of Sciences
Presented by Biogen Idec and the New York Academy of Sciences
Demyelinating diseases and disorders affect millions of people worldwide. While multiple sclerosis is the one of the most widely recognized myelin-associated disorders, changes to the brain’s white matter can be found in a number of genetic, inflammatory, infectious, cerebrovascular, and neurodegenerative conditions and injuries. New breakthroughs in basic science research on the white matter microenvironment and oligodendrocyte precursor cell development have provided novel potential sites of action for therapeutics. Translation of these discoveries into biomarkers to predict clinical outcomes, and into biologics that can modulate myelination utilizing these pathways, may transform the treatment of currently incurable conditions.
This one-day, translational conference will present recent findings in remyelination and repair from disease models and clinical trials, new techniques for imaging myelination changes in the brain and for screening molecular targets, and emerging therapeutics that promote remyelination.
Call for Abstracts
The deadline for poster abstract submission is Monday, May 5, 2014.
Select poster abstracts will be chosen for short oral presentations. For complete abstract submission instructions, please send an email to email@example.com with "Abstract Information" in the subject line. There is no need to type a message; instructions will be forwarded automatically. Please call 212.298.8620 with any questions.
Call for Early Career Investigator Travel Fellowship Applications
The deadline for submission of applications is Monday, May 5, 2014.
Applications are invited from qualified early career investigators and early career investigators from underrepresented minorities. For detailed information on eligibility and application instructions, please send an email to firstname.lastname@example.org with the words "Fellowship Information" in the subject line. There is no need to type a message; instructions will be forwarded automatically. Please call 212.298.8620 with any questions.